Security Snapshot

EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) Institutional Ownership

CUSIP: 30233G209

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

185

Shares (Excl. Options)

88,510,788

Price

$12.89

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Security identity
Issuer context
Shares outstanding
82,695,711
Reported price per share
$13.43
Price from insider filings
$13.43
Latest holder snapshot
Portfolio coverage rank
0%
Share change
+5,469,161
Value change
+$42,505,333
Number of holders
185
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • EYPT - EyePoint, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 30233G209.
  • 185 institutions reported positions in Q1 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 165 to 185 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,524,932,141 to $1,140,946,477.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 185 institutions filings for Q1 2026.

Open SEC Evidence

Security key

30233G209

Latest holder period

Q1 2026

13F holders

185

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
EYPT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 10% $99,097,350 8,265,000 Cormorant Asset Management, LP 04 Dec 2025
FEDERATED HERMES, INC. 6.7% $43,281,744 4,599,450 Federated Hermes, Inc. 30 Jun 2025
BlackRock, Inc. 6.5% $63,872,124 4,485,402 BlackRock, Inc. 30 Sep 2025
FRANKLIN RESOURCES INC 6.1% -18% $27,059,688 +$820,894 4,137,567 +3.1% Franklin Resources, Inc. 31 Dec 2024
TCG Crossover GP II, LLC 4.3% $62,265,799 3,572,335 TCG Crossover GP II, LLC 31 Dec 2025
Adage Capital Management, L.P. 4% -29% $46,827,000 -$19,866,000 3,300,000 -30% Adage Capital Management, L.P. 31 Mar 2026
RA CAPITAL MANAGEMENT, L.P. 4.7% $20,809,090 3,181,818 RA Capital Management, L.P. 31 Dec 2024
Paradigm Biocapital Advisors LP 3.8% -26% $44,591,181 -$14,897,003 3,142,437 -25% Paradigm BioCapital Advisors LP 31 Mar 2026

As of 31 Mar 2026, 185 institutional investors reported holding 88,510,788 shares of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT). This represents 107% of the company’s total 82,695,711 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 10% 8,296,375 +6% 2.9% $106,940,274
Cormorant Asset Management, LP 10% 8,265,000 0% 5.4% $106,535,850
BlackRock, Inc. 8.7% 7,177,337 +5.7% 0% $92,515,874
FEDERATED HERMES, INC. 6.9% 5,669,589 -5.8% 0.12% $73,081,003
FRANKLIN RESOURCES INC 6.1% 5,048,598 +1.4% 0.02% $65,076,424
JANUS HENDERSON GROUP PLC 4.4% 3,601,168 +23% 0.02% $46,419,056
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 3,559,569 0% 0% $45,882,844
ADAGE CAPITAL PARTNERS GP, L.L.C. 4% 3,300,000 -30% 0.07% $42,537,000
Paradigm Biocapital Advisors LP 3.8% 3,142,437 -15% 0.83% $40,506,013
Commodore Capital LP 3.4% 2,825,000 2.1% $36,414,250
STATE STREET CORP 2.5% 2,097,202 +14% 0% $27,032,934
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,983,665 +4.4% 0% $25,573,730
CITADEL ADVISORS LLC 2.3% 1,905,875 0.02% $24,566,729
Aberdeen Group plc 2.1% 1,738,378 +8.2% 0.04% $22,407,692
Balyasny Asset Management L.P. 1.7% 1,438,737 +142% 0.04% $18,545,320
Parkman Healthcare Partners LLC 1.6% 1,354,800 +25% 1.8% $17,463,372
EVENTIDE ASSET MANAGEMENT, LLC 1.5% 1,245,583 0.27% $16,055,565
MORGAN STANLEY 1.3% 1,096,109 +390% 0% $14,128,844
Essex Woodlands Management, Inc. 1.3% 1,084,857 0% 5.6% $13,983,807
ORBIMED ADVISORS LLC 1.3% 1,069,147 -57% 0.31% $13,781,305
5AM Venture Management, LLC 1.3% 1,050,000 0% 3.8% $13,534,500
Rosalind Advisors, Inc. 1.3% 1,036,737 +50% 5.5% $13,363,540
Blue Owl Capital Holdings LP 1.1% 912,594 +132% 3.2% $11,763,337
HSBC HOLDINGS PLC 1% 833,455 0.01% $10,743,235
STEMPOINT CAPITAL LP 0.98% 810,764 +129% 2% $10,450,748

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 88,510,788 $1,140,946,477 +$42,505,333 $12.89 185
2025 Q4 83,462,311 $1,524,932,141 +$249,855,302 $18.27 165
2025 Q3 69,898,687 $995,227,037 +$20,107,476 $14.24 148
2025 Q2 68,912,118 $648,484,078 -$21,934,653 $9.41 139
2025 Q1 74,070,140 $401,203,753 -$6,558,607 $5.42 149
2024 Q4 74,299,852 $553,357,101 +$114,467,368 $7.45 141
2024 Q3 58,498,731 $476,138,776 -$4,424,916 $7.99 135
2024 Q2 58,415,381 $508,206,601 -$17,769,473 $8.70 148
2024 Q1 55,009,467 $1,137,046,639 +$106,318,844 $20.67 161
2023 Q4 49,565,894 $1,145,491,759 +$422,510,894 $23.11 138
2023 Q3 33,709,262 $269,337,991 +$16,845,118 $7.99 98
2023 Q2 31,573,084 $274,685,383 +$22,852,995 $8.70 82
2023 Q1 29,111,970 $85,592,348 -$1,206,242 $2.94 66
2022 Q4 29,377,926 $102,818,972 -$13,441,865 $3.50 72
2022 Q3 30,106,241 $238,140,639 -$883,849 $7.91 82
2022 Q2 30,200,779 $237,683,742 -$3,357,027 $7.87 78
2022 Q1 30,440,222 $369,919,357 +$7,173,181 $12.15 78
2021 Q4 29,839,293 $365,363,130 +$94,551,507 $12.24 83
2021 Q3 22,128,108 $230,547,815 +$14,765,407 $10.42 61
2021 Q2 20,739,059 $186,447,743 +$7,944,014 $8.99 59
2021 Q1 19,642,118 $199,571,620 +$124,369,380 $10.16 58
2020 Q4 7,703,318 $50,684,935 +$50,684,935 $6.58 31
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .